Inventor · disambiguated record
Andrew George Popplewell
Also filed as: POPPLEWELL ANDREW G · POPPLEWELL ANDREW GEORGE
35 granted patents·15 pending applications·508 citations·filing 2001–2022
98Inventor score
Top patents by PatentIndex Score
50 records- 0195US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0295US8293237B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofBURKLY LINDA C·Filed 2008·Granted Oct 23, 2012·40 cites·19 claims
- 0395US8153768B2Calicheamicin derivative-carrier conjugatesKUNZ ARTHUR·Filed 2003·Granted Apr 10, 2012·114 cites·5 claims
- 0494US8614295B2Antibody molecules having specificity for human OX40LAWSON ALASTAIR DAVID GRIFFITHS·Filed 2010·Granted Dec 24, 2013·41 cites·29 claims
- 0593US8303953B2Antibody molecules which bind IL-17A and IL-17FADAMS RALPH·Filed 2007·Granted Nov 6, 2012·18 cites·12 claims
- 0692US8057794B2Antibody molecules which bind to human IL-17RAPECKI STEPHEN EDWARD·Filed 2007·Granted Nov 15, 2011·26 cites·12 claims
- 0792US7012135B2Biological productsCELLTECH CHIROSCIENCE LTD·Filed 2001·Granted Mar 14, 2006·63 cites·3 claims
- 0891US9428570B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2013·Granted Aug 30, 2016·18 cites·22 claims
- 0991US8231875B2Neutralising antibody molecules having specificity for human IL-17ADAMS RALPH·Filed 2005·Granted Jul 31, 2012·15 cites·9 claims
- 1089US7355011B2Biological productsUCB PHARMA SA·Filed 2003·Granted Apr 8, 2008·21 cites·5 claims
- 1188US8835611B2Calicheamicin derivative-carrier conjugatesKUNZ ARTHUR·Filed 2012·Granted Sep 16, 2014·10 cites·40 claims
- 1288US7419659B2Expression control using variable intergenic sequencesUCB PHARMA SA·Filed 2002·Granted Sep 2, 2008·17 cites·6 claims
- 1387US7402662B2Antibody molecules specific to human tumor necrosis factor alphaUCB PHARMA SA·Filed 2006·Granted Jul 22, 2008·12 cites·2 claims
- 1486US8329431B2Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17ADAMS RALPH·Filed 2011·Granted Dec 11, 2012·6 cites·17 claims
- 1583US8486662B2DNA encoding antibody molecules having specificity for human IL-6GELINAS RICHARD EVAN·Filed 2011·Granted Jul 16, 2013·6 cites·15 claims
- 1683US8075889B2Antibody molecules having specificity for human IL-6GELINAS RICHARD EVAN·Filed 2006·Granted Dec 13, 2011·6 cites·7 claims
- 1782US9351986B2Calicheamicin derivative-carrier conjugatesWYETH HOLDINGS LLC·Filed 2014·Granted May 31, 2016·4 cites·22 claims
- 1881US8465744B2Method of treating inflammation by administering human IL-1B antibodiesLAWSON ALASTAIR DAVID GRIFFITHS·Filed 2009·Granted Jun 18, 2013·4 cites·20 claims
- 1981US7977464B2Antibody molecules specific to human tumour necrosis factor alphaUCB PHARMA SA·Filed 2008·Granted Jul 12, 2011·3 cites·22 claims
- 2080US8747857B2Calicheamicin derivative-carrier conjugatesKUNZ ARTHUR·Filed 2003·Granted Jun 10, 2014·10 cites·96 claims
- 2180US2023135399A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 2279US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 2379US8435761B2DNA encoding antibody molecules which bind human IL-17RAPECKI STEPHEN EDWARD·Filed 2011·Granted May 7, 2013·4 cites·6 claims
- 2478US10308723B2Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17FUCB BIOPHARMA SPRL·Filed 2017·Granted Jun 4, 2019·1 cites·9 claims
- 2578US8865167B2Neutralising antibody molecules having specificity for human IL-17UCB PHARMA SA·Filed 2012·Granted Oct 21, 2014·2 cites·7 claims
- 2678US7919606B2Biological productsUCB PHARMA SA·Filed 2008·Granted Apr 5, 2011·1 cites·10 claims
- 2777US9096668B2Methods for making antibody molecules having specificity for human IL-6UCB PHARMA SA·Filed 2013·Granted Aug 4, 2015·2 cites·3 claims
- 2877US7608694B2Antibody molecules having specificity for human IL-1βUCB PHARMA SA·Filed 2004·Granted Oct 27, 2009·8 cites·21 claims
- 2976US7186820B2Production of humanised antibodies to TNFαUCB CELLTECH·Filed 2001·Granted Mar 6, 2007·10 cites·12 claims
- 3074US9890219B2Methods of treating an IL-17A mediated pathological conditionUCB BIOPHARMA SPRL·Filed 2015·Granted Feb 13, 2018·1 cites·14 claims
- 3174US9249232B2Framework selectionADAMS RALPH·Filed 2007·Granted Feb 2, 2016·1 cites·10 claims
- 3274US8617847B2Nucleic acids encoding antibody molecules which bind IL-17A and IL-17FUCB PHARMA SA·Filed 2012·Granted Dec 31, 2013·1 cites·17 claims
- 3373US9631015B2Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6UCB PHARMA SA·Filed 2015·Granted Apr 25, 2017·1 cites·7 claims
- 3466US2019233530A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 3565US2015147331A1Neutralising Antibody Molecules having Specificity for Human IL-17UCB PHARMA SA·Filed 2014·Application pending·0 cites
- 3664US2018339058A1Calicheamicin derivative-carrier conjugatesWYETH HOLDINGS LLC·Filed 2018·Application pending·0 cites
- 3764US2014186355A1Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17FUCB PHARMA SA·Filed 2013·Application pending·0 cites
- 3863US7452976B2Biological productsUCB PHARMA SA·Filed 2002·Granted Nov 18, 2008·2 cites·30 claims
- 3963US2014044732A1Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17FUCB PHARMA SA·Filed 2013·Application pending·0 cites
- 4063US2017145114A1Biological productsUCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
- 4163US2007059307A1Biological productsCELLTECH R&D LTD·Filed 2006·Application pending·0 cites
- 4261US2016326247A1Biological productsUCB BIOPHARMA SPRL·Filed 2016·Application pending·0 cites
- 4361US2017275355A1Neutralising antibody molecules having specificity for human il-17UCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
- 4461US2012302739A1Biological productsPOPPLEWELL ANDREW GEORGE·Filed 2012·Application pending·0 cites
- 4558US2017182159A1Antibody molecules having specificity for human il-6UCB PHARMA SA·Filed 2017·Application pending·0 cites
- 4658US2016251429A1Neutralising antibody molecules having specificity for human il-17UCB PHARMA SA·Filed 2016·Application pending·0 cites
- 4758US2016200823A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB PHARMA SA·Filed 2016·Application pending·0 cites
- 4857US10017575B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2016·Granted Jul 10, 2018·0 cites·32 claims
- 4957US7842787B2Biological productsUCB PHARMA SA·Filed 2007·Granted Nov 30, 2010·0 cites·11 claims
- 5057US2016303252A1Calicheamicin derivative-carrier conjugatesWYETH HOLDINGS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew George Popplewell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →